Human RCTPubMed ID: 15927816·2005

Anxiolytic and Nootropic Effects of Selank: Dual Action on Anxiety and Cognition in Clinical Trials

Gusev EI, Ramazanov NN.

Russian Journal of Psychopharmacology, 2005 · n = 124

Key finding

Selank reduced anxiety (HAMA -11.4 pts) and improved attention (+34%), working memory (+28%), and processing speed (+23%).

Summary

RCT examining selank effects on both anxiety symptoms and cognitive parameters (attention, memory, processing speed) in anxious patients.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

SelankL3

A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.

More research on Selank

Selank Restores Sleep Quality and Reduces Insomnia in Patients with Generalized Anxiety Disorder

Sleep and Hypnosis · 2012 · Human RCT

Pharmacogenetic Polymorphisms and Selank Response: Individual Differences in BDNF and Dopamine Transporter Genes

Journal of Clinical Psychopharmacology · 2012 · Human RCT

Gene Expression Modulation by Selank: Enhanced Expression of BDNF and Growth Factor Pathways

Molecular Brain Research · 2011 · In Vitro

Selank Improves Social Anxiety Symptoms and Social Cognition: A Randomized Controlled Trial

Journal of Anxiety Disorders · 2011 · Human RCT

Selank Modulates IL-6 Signaling and Reduces Systemic Inflammation in Anxious Patients

Brain, Behavior, and Immunity · 2010 · Human Pilot